- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 513/04
Total number of patents in this class: 4193
10-year publication summary
|
227
|
219
|
270
|
282
|
273
|
252
|
238
|
278
|
286
|
258
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
88 |
| Merck Patent GmbH | 5752 |
77 |
| F. Hoffmann-La Roche AG | 7937 |
70 |
| Merck Sharp & Dohme LLC | 3732 |
66 |
| Boehringer Ingelheim International GmbH | 4636 |
64 |
| Takeda Pharmaceutical Company Limited | 2721 |
59 |
| Janssen Pharmaceutica N.V. | 3358 |
58 |
| Hoffmann-La Roche Inc. | 3546 |
56 |
| Genentech, Inc. | 4016 |
53 |
| Daiichi Sankyo Company, Limited | 1879 |
50 |
| Novartis AG | 10612 |
46 |
| BASF SE | 21098 |
46 |
| Achillion Pharmaceuticals, Inc. | 164 |
46 |
| Amgen Inc. | 4256 |
43 |
| Gilead Sciences, Inc. | 2106 |
42 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
36 |
| Incyte Corporation | 1039 |
34 |
| FUJIFILM Corporation | 29839 |
33 |
| Sumitomo Chemical Company, Limited | 9109 |
32 |
| Abbvie Inc. | 1817 |
31 |
| Other owners | 3163 |